Company: CARsgen Therapeutics
Job title: SVP, Clinical Development
Dr. Hong MA is a clinical oncologist with 20 years of cancer immunotherapy and orphan drug development experience, including over 15 years of pharmaceutical industry experience. He has in-depth experience in cellular therapy programs in the U.S. and EMA region with 8 IND & CTA approvals. Before joining in CARsgen, he served as the senior medical director & senior director of clinical development at Immatics Biotechnologies GmbH. Prior to this role, he was the director of clinical development at Bellicum Pharmaceutical, Inc. and was the director of clinical operation at Endocyte Pharmaceutical (now the part of Novartis Oncology).